EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Advances, challenges, and prospects of electroencephalography-based biomarkers for psychiatric disorders: a narrative review

Seokho Yun

Journal of Yeungnam Medical Science · 31.10.2024 · 41 (4) · 261-268

DOI: 10.12701/jyms.2024.00668 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Yeungnam Medical Science, erschienen am 31.10.2024. Verfasst von Seokho Yun. Beteiligte Einrichtung: Department of Psychiatry, Yeungnam University College of Medicine, Daegu, Korea. Die Arbeit wurde bisher 42-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Owing to a lack of appropriate biomarkers for accurate diagnosis and treatment, psychiatric disorders cause significant distress and functional impairment, leading to social and economic losses. Biomarkers are essential for diagnosing, predicting, treating, and monitoring various diseases. However, their absence in psychiatry is linked to the complex structure of the brain and the lack of direct monitoring modalities. This review examines the potential of electroencephalography (EEG) as a neurophysiological tool for identifying psychiatric biomarkers. EEG noninvasively measures brain electrophysiological activity and is used to diagnose neurological disorders, such as depression, bipolar disorder (BD), and schizophrenia, and identify psychiatric biomarkers. Despite extensive research, EEG-based biomarkers have not been clinically utilized owing to measurement and analysis constraints. EEG studies have revealed spectral and complexity measures for depression, brainwave abnormalities in BD, and power spectral abnormalities in schizophrenia. However, no EEG-based biomarkers are currently used clinically for the treatment of psychiatric disorders. The advantages of EEG include real-time data acquisition, noninvasiveness, cost-effectiveness, and high temporal resolution. Challenges such as low spatial resolution, susceptibility to interference, and complexity of data interpretation limit its clinical application. Integrating EEG with other neuroimaging techniques, advanced signal processing, and standardized protocols is essential to overcome these limitations. Artificial intelligence may enhance EEG analysis and biomarker discovery, potentially transforming psychiatric care by providing early diagnosis, personalized treatment, and improved disease progression monitoring.

Schlagwörter

Stichwörter der Autor:innen

Artificial intelligenceBiomarkersElectroencephalographyMental disorders

Autor:innen und Institutionen

  • Department of Psychiatry, Yeungnam University College of Medicine, Daegu, Korea.

Zitieren

APA

Yun, S. (2024). Advances, challenges, and prospects of electroencephalography-based biomarkers for psychiatric disorders: a narrative review. Journal of Yeungnam Medical Science, 41(4), 261-268. https://doi.org/10.12701/jyms.2024.00668

Vancouver

Yun S. Advances, challenges, and prospects of electroencephalography-based biomarkers for psychiatric disorders: a narrative review. Journal of Yeungnam Medical Science. 2024;41(4):261-268. doi:10.12701/jyms.2024.00668

BibTeX
@article{Yun2024,
  author = {Yun, Seokho},
  title = {Advances, challenges, and prospects of electroencephalography-based biomarkers for psychiatric disorders: a narrative review},
  journal = {Journal of Yeungnam Medical Science},
  year = {2024},
  volume = {41},
  number = {4},
  pages = {261--268},
  doi = {10.12701/jyms.2024.00668}
}
Kostenlos starten →